10,636 Shares in Astera Labs, Inc. $ALAB Purchased by Belpointe Asset Management LLC

Belpointe Asset Management LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,636 shares of the company’s stock, valued at approximately $962,000.

Several other hedge funds have also recently added to or reduced their stakes in ALAB. Oliver Lagore Vanvalin Investment Group acquired a new position in Astera Labs in the second quarter worth about $29,000. Sound Income Strategies LLC grew its stake in Astera Labs by 34.7% during the first quarter. Sound Income Strategies LLC now owns 792 shares of the company’s stock worth $47,000 after buying an additional 204 shares during the last quarter. GAMMA Investing LLC grew its stake in Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after buying an additional 284 shares during the last quarter. Harbour Investments Inc. grew its stake in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after buying an additional 619 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in Astera Labs during the first quarter worth about $48,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This represents a 25.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $191.19, for a total transaction of $19,119,000.00. Following the completion of the transaction, the chief financial officer owned 401,496 shares in the company, valued at $76,762,020.24. This represents a 19.94% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,320,054 shares of company stock valued at $215,638,632. 12.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ALAB. Bank of America began coverage on shares of Astera Labs in a research note on Friday, October 3rd. They set a “neutral” rating and a $230.00 price objective on the stock. Barclays reaffirmed an “overweight” rating and set a $155.00 price objective (up from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, September 2nd. Needham & Company LLC increased their price target on shares of Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Finally, Stifel Nicolaus set a $145.00 price target on shares of Astera Labs and gave the company a “buy” rating in a research note on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $159.83.

Astera Labs Price Performance

ALAB opened at $212.10 on Wednesday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company’s 50 day simple moving average is $193.63 and its 200-day simple moving average is $121.53. The stock has a market capitalization of $35.26 billion, a P/E ratio of 378.75, a price-to-earnings-growth ratio of 5.50 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. During the same period in the prior year, the firm earned $0.13 earnings per share. Astera Labs’s revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.